Next Article in Journal
Relationship of Cultivated Grain Amaranth Species and Wild Relative Accessions
Next Article in Special Issue
The Regulatory Hierarchy Following Signal Integration by the CbrAB Two-Component System: Diversity of Responses and Functions
Previous Article in Journal
RDAClone: Deciphering Tumor Heterozygosity through Single-Cell Genomics Data Analysis with Robust Deep Autoencoder
Previous Article in Special Issue
Metagenomic Analyses of Plant Growth-Promoting and Carbon-Cycling Genes in Maize Rhizosphere Soils with Distinct Land-Use and Management Histories
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Identification of the EdcR Estrogen-Dependent Repressor in Caenibius tardaugens NBRC 16725: Construction of a Cellular Estradiol Biosensor

Center for Biological Research Margarita Salas, Department of Microbial and Plant Biotechnology, Spanish National Research Council, Ramiro de Maeztu 9, 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Genes 2021, 12(12), 1846; https://doi.org/10.3390/genes12121846
Submission received: 25 October 2021 / Revised: 19 November 2021 / Accepted: 21 November 2021 / Published: 23 November 2021
(This article belongs to the Special Issue Regulation of Microbial Biosynthetic Genes and Biodegradation Genes)

Abstract

:
In this work, Caenibius tardaugens NBRC 16725 (strain ARI-1) (formerly Novosphingobium tardaugens) was isolated due to its capacity to mineralize estrogenic endocrine disruptors. Its genome encodes the edc genes cluster responsible for the degradation of 17β-estradiol, consisting of two putative operons (OpA and OpB) encoding the enzymes of the upper degradation pathway. Inside the edc cluster, we identified the edcR gene encoding a TetR-like protein. Genetic studies carried out with C. tardaugens mutants demonstrated that EdcR represses the promoters that control the expression of the two operons. These genetic analyses have also shown that 17β-estradiol and estrone, the second intermediate of the degradation pathway, are the true effectors of EdcR. This regulatory system has been heterologously expressed in Escherichia coli, foreseeing its use to detect estrogens in environmental samples. Genome comparisons have identified a similar regulatory system in the edc cluster of Altererythrobacter estronivorus MHB5, suggesting that this regulatory arrangement has been horizontally transferred to other bacteria.

1. Introduction

Endocrine disruptors (EDCs) are chemical contaminants that interfere with the endocrine system and produce adverse effects in both humans and wildlife. The exposure to estrogens, in concentrations as low as 1 ng/L, has been reported to cause feminization, decreased expression of secondary sex characteristics and a reduction in egg fertilization in fish and amphibians [1]. Natural estrogens and androgens enter the environment through the excretions of humans, domestic or farm animals and wildlife. The 17β-estradiol (E2) is a ubiquitous pollutant usually found in soil and water systems [2,3,4]. The complete mineralization of estrogens to CO2 can be accomplished aerobically [5,6,7,8,9,10,11,12,13,14] or anaerobically [15] by a limited number of bacteria, mainly from the phyla Proteobacteria and Actinobacteria. Different biochemical and genetic studies have assigned function to many catabolic genes involved in estrogen catabolism, but numerous issues concerning the degradative pathway and its regulation remain to be fully elucidated [10,16,17,18,19].
Caenibiustardaugens (formerly Novosphingobium tardaugens) is an aerobic bacterium, isolated from a sewage treatment plant in Tokyo due to its capacity to mineralize E2 and other EDCs [5,20]. Taking advantage of the fact that the genome of this bacterium has been recently assembled in a single contig [21], we have used it as a model system to study the degradation pathways that mineralize EDCs [22,23] (Figure 1).
These studies have allowed us to identify two gene clusters, named SD and edc, responsible for the degradation of testosterone (TES) and E2, respectively [22,23]. The transcriptomic analysis enabled the characterization of the edc cluster that is organized in two divergent operons, OpA (EGO55_13525–EGO55_13565) and OpB (EGO55_13570–EGO55_13600), and a divergently expressed gene, EGO55_13520, which encodes a putative TetR-like transcriptional regulator [23] (Figure 2). The E2 degradation pathway is tightly regulated, reinforcing the idea that the TetR-like protein could play a regulatory role [23]. The TetR family of regulators is a large family of one-component bacterial signal transduction systems and their regulatory mechanisms, as well as their large variety of effectors, have been extensively studied [24,25]. Although some of these regulators have been proposed to be involved in the metabolism of steroid compounds in bacteria, none have been experimentally shown to interact specifically with estrogens (see discussion).
In this work, we demonstrate that EdcR regulates the edc cluster in C. tardaugens. This regulator acts as a repressor of the expression of the edc cluster genes. We determined that E2 and E1 work as effectors to de-repress the system. By heterologously expressing this regulatory system in Escherichia coli, we constructed a cell biosensor to detect the presence of E2 and E1 in environmental samples.

2. Materials and Methods

2.1. Chemicals

Testosterone (TES), 17β-estradiol (E2), estrone (E1), 4-hydroxyestrone (4-OHE1), estriol (E3), ethinylestradiol (EE2), pyruvate (Pyr), chloroform, n-hexane, ethyl acetate, sulphuric acid and acetonitrile were purchased from Sigma (Steinheim, Germany). Randomly methylated β-cyclodextrin (TRMB-T Randomly Methylated BCD) (CDX) was purchased from Cyclodex (Alachua, FL, United States).

2.2. Strains and Growth Media

Bacterial strains and plasmids used in this study are listed in Table 1. C. tardaugens NBRC 16725 (strain ARI-1) was purchased from the Leibniz-Institut DSMZ type culture collection. Nutrient broth (NB) (DifcoTM, Burlington, NJ, USA) was used as rich medium to grow this strain at 30 °C in an orbital shaker at 200 rpm. This strain was also cultured in minimal medium M63 [KH2PO4 (136 g/L), (NH4)2SO4 (20 g/L), FeSO4·7H2O (5 mg/L), pH 7.0] supplemented with 0.39 mM CaCl2, 1 mM MgSO4 and different carbon sources. Steroids and pyruvate stock solutions were prepared in PBS buffer and 70 mM CDX to reach a final carbon concentration of 54 mM in 20 mM CDX in the culture medium. Escherichia coli DH10B was grown at 37 °C in an orbital shaker at 200 rpm in lysogeny broth (LB) medium [26]. The appropriate antibiotics, chloramphenicol (34 µg/mL), kanamycin (50 µg/mL) or rifampicin (50 µg/mL) were added when needed.

2.3. DNA Manipulation

Molecular biology and DNA manipulations were performed as described elsewhere [27]. C. tardaugens genomic DNA was extracted as described before [21]. Plasmid DNA was purified using High Pure Plasmid Isolation Kit (Roche, Basel, Switzerland). DNA fragments were purified with QIAquick PCR Purification Kit (Qiagen, Düsseldorf, Germany) or QIAquick Gel Extraction Kit (Qiagen, Düsseldorf, Germany). E. coli cells were transformed using the RbCl method or by electroporation (Gene Pulser; Bio-Rad, Hercules, USA) [31]. DNA amplification was performed in a Mastercycler Gradient (Eppendorf, Hamburg, Germany) using the oligonucleotides listed in Table S1, which were purchased from Sigma (Steinheim, Germany). Phusion High-Fidelity DNA Polymerase (New England Biolabs (NEB), Ipswich, MA, USA) was used for cloning amplifications and Taq DNA polymerase (Biotools, Madrid, Spain) for screening and RT-PCR assays. All PCR products were checked by agarose gel electrophoresis and those aimed for cloning were confirmed by DNA sequencing by Secugen S.L. (Madrid, Spain). Digestion of DNA fragments was done using restriction enzymes from NEB and ligation was performed with Instant Sticky-end Ligase Master Mix (NEB). Construction of pSEVA237MPb was performed as follows: first digesting pSEVA237M-BCD2-14g with PacI and AvrII restriction enzymes to excise 14 g promoter; then digesting pSEVA237Pb-edcA [23] using PacI and XbaI restriction enzymes to extract Pb promoter and finally ligating the core of pSEVA237M-BCD2 plasmid with Pb promoter fragment (Figure S1). pSEVA65edcR plasmid was constructed digesting pSEVA23edcR with PacI and SpeI restriction enzymes to extract a DNA fragment containing PlexA promoter and edcR gene and ligating it into pSEVA651 plasmid backbone.

2.4. RNA Manipulation

Total RNA of C. tardaugens cells was extracted from 12 ml of cultures grown in minimal medium with 20 mM CDX and TES or pyruvate as carbon sources. Cells were harvested in mid exponential phase (OD600 0.6) and stored at −80 °C. Pellets were thawed and cells were lysed in 400 µL TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) containing lysozyme (50 mg/mL) following three freezing/thawing cycles. High Pure Isolation Kit (Roche, Basel, Switzerland), followed by DNA-freeTM DNA Removal Kit (Invitrogen, Waltham, MA, USA) treatment, was used to obtained pure RNA. Purity and concentration were measured in a ND1000 spectrophotometer (Nanodrop Technologies, Thermo Fisher Scientific, Waltham, MA, USA). cDNA used as the template for RT-PCR was obtained with a Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, Switzerland) following the manufacturer’s instructions, where 1 µg of total RNA was used as the template in 20 µL of reverse transcription reaction. RT-PCR was performed adding 1 µL of cDNA, 0.5 mM of each oligonucleotide, 0.25 mM dNTPs, 5% DMSO (v/v) and 1 U of Taq DNA polymerase to a reaction mixture of 30 µL in a 20-cycle PCR. Oligonucleotides used in RT-PCR expression analysis are listed in Table S1. To check that RNA was not contaminated with DNA, a 30-cycle PCR was performed using 200 ng total RNA as template and oligonucleotides 5RTRecAf and 5RTRecAr (Table S2).

2.5. Construction of C. tardaugens Knockout Strains

The knockout strains were constructed by double homologous recombination using the suicide vector pK18mobsacB [28] as described before [22]. C. tardaugens genomic DNA was used as template to amplify two fragments of ≈700 bp containing the upstream and downstream regions of the gene to delete UP and DOWN fragments (Table 1 and Table S1), respectively. The fragments were digested with the appropriate restriction enzymes and cloned in the unique sites of the plasmid. The ligation product was transformed into E. coli DH10B competent cells and once recombinant candidates were PCR-checked, the cloned region was confirmed by sequencing. The plasmids were transformed by triparental conjugation [32] into C. tardaugens RfR as recipient strain using E. coli HB101 (pRK600) [33] as a helper and E. coli DH10B, harboring the corresponding vector, as a donor, as described before [23].

2.6. Complementation of C. tardaugens Knockout Strains

The mutant strains were transformed with pSEVA23 plasmids harboring the corresponding deleted genes under the expression control of PlexA constitutive promoter [29] (Table 1) using triparental conjugation, following the same protocol used to construct C. tardaugens knockout strains.

2.7. Fluorescence Measurement of Cultures on a Plate Reader

The fluorescence signal of GFP (Green Fluorescent Protein) in cultures of strains carrying transcriptional fusions was measured using a Varioskan Flash microplate reader (Thermo Scientific, Waltham, MA, USA), using excitation and emission wavelengths of 485 nm and 511 nm, respectively. The measurements were made in 96-well plates and three technical replicates of each sample were taken into three different wells. The measurement was performed by loading into each well 200 µL of cells at an OD600 of 1.0, previously washed with 0.85% (w/v) NaCl solution in H2Omq. The measurements were normalized to OD and to a control where no GFP (only 0.85% (w/v) NaCl solution in H2Omq) was used.

2.8. In Silico Genomic Analysis

Analysis of nucleotide sequences, chromatograms from sequencing reactions, design of genetic engineering experiments, design and analysis of oligonucleotides and mapping of reads obtained from transcriptome sequencing against the C. tardaugens genome, were done with the program Geneious R11.1.5 (https://www.geneious.com, accessed on 25 October 2021). Identification of conserved promoter sequences with was performed using the tools BPROM [34] from the Softberry server (https://www.softberry.com, accessed on 25 October 2021) and SAPPHIRE [35] (https://www.biosapphire.com, accessed on 25 October 2021). Gene product prediction was done with Rapid Annotations using Subsystems Technology (RAST) [36]. Amino acid sequences of individual proteins were compared with those in the databases by using the BLASTp program [37] from the National Center for Biotechnology Information (NCBI; https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 25 October 2021) server. Multiple alignments of nucleotide and amino acid sequences were performed with ClustalOmega [38] from the server of the European Bioinformatics Institute (EMBL-EBI; http://www.ebi.ac.uk/Tools/msa/clustalo/, accessed on 25 October 2021).

3. Results

3.1. In Silico Analysis of the Main Promoters Responsible for the Expression of C. tardaugens Edc Gene Cluster

Transcriptomic studies have revealed a high induction level of the edc cluster genes in the presence of E2 [23]. The structure of the edc cluster suggests the existence of two promoters in the intergenic region located between the divergent OpA and OpB putative operons, and at least another promoter upstream the EGO55_13520 (edcR) gene, encoding a putative regulatory protein EdcR that is divergently transcribed to the OpA genes (Figure 2). Furthermore, the large intergenic region of 85 bp between the EGO55_13595 and EGO55_13600 genes suggests the presence of another promoter region that can drive the expression of the EGO55_13600 (edcT) gene, encoding a putative transporter (Figure 2).
To get a whole picture of the edc gene expression, the raw reads obtained in the RNAseq experiments carried out in the presence of E2 or Pyr were mapped against the genome sequence. As expected, the result reflected a higher number of reads when cells were grown in the presence of E2, which corresponds to the higher level of induction already described (Figure 3). In both conditions, the intergenic region between the EGO55_13565 and EGO55_13570 genes (i.e., the initial genes of the OpA and OpB divergent operons, respectively) showed a low number of aligned reads (i.e., an aligning gap) compared with the reads aligned to both catabolic genes, suggesting that this region could contain the two promoters which drive the expression of both operons (Figure 3). A less pronounced aligning gap, but still significant, was observed upstream of the EGO55_13520 gene suggesting the existence of another promoter region (Figure 3).
Interestingly, Figure 3 also shows that in the Pyr condition, the number of reads mapped at the EGO55_13520 (edcR) gene was proportionally higher than the average of the reads mapped to the rest of the catabolic genes, suggesting that this gene was more expressed than the other genes of the edc cluster in the absence of E2. When the expression of the edcR regulatory gene was more precisely compared with the expression of the other genes of edc cluster using the number of normalized reads, we observed that the average of normalized reads mapped to EGO55_13520 gene when cells are cultured on Pyr (1553 transcripts per kilobase million, TPMs) was higher than the reads mapped to OpA (239 TPMs) and OpB (889 TPMs) operons [23]. However, when cells are cultured on E2, edcR had slightly less reads per transcription unit (9390 TPMs) than the reads of OpA (14401 TPMs) and OpB (22708 TPMs) operons [23]. This suggests that EdcR might act as a repressor during growth on Pyr, a condition in which the genes of the edc cluster are silenced.
It is also worth mentioning that Figure 3 does not show an aligning gap at the end of the OpB operon and the beginning of the EGO55_13600 (edcT) gene, likely suggesting that this gene can be expressed not only by its own promoter, but also by the promoter of the OpB operon.
On the other hand, the transcriptomic analysis revealed a higher induction of the genes of the OpA operon compared to those of the OpB operon, likely due to an overall low expression level in PYR condition of genes of the OpA operon (239 TPMs) compared to those of the OpB operon (889 TPMs) (Figure 3c). Furthermore, there is a significant difference in the expression levels between the EGO55_13595 gene belonging to the OpB operon and EGO55_13600 gene, suggesting, as pointed out above, the presence of an additional promoter element driving the expression of the EGO55_13600 gene (Figure 3a,c).
Therefore, these analyses support the existence of at least four promoter regions in the edc cluster, i.e., Pr, Pt, Pa and Pb, to control transcription of edcR and edcT genes, and OpA and OpB operons, respectively (Figure 3).
The promoter regions were analyzed to detect the putative RNA polymerase binding sequences (boxes -10 and -35), as well as the possible operator binding sequences for transcriptional factors using bioinformatic tools (see Materials and Methods). Possible -10 and -35 boxes were identified in these regions, but the boxes of Pb promoter were more similar to the consensus -10 (TATAAT) and -35 (TTGACA) boxes of E. coli [39] (Figure 4). On the other hand, a conserved palindromic sequence (TnnCnnTACnAnTnGTAnnGnnA) was identified in the Pa and Pb promoters as a putative operator site. A similar but less conserved sequence was also identified at Pr and Pt ‘promoters. This putative operator sequence is overlapping the -10 box in all these promoters (Figure 4).
When the promoter regions of C. tardaugens were compared with the equivalent regions of the edc homologous gene clusters of the estrogen-degrading bacteria Altererythrobacter estronivorus MHB5 and Sphingomonas sp. KC8 [10,14], we observed only highly conserved sequences in the C. tardaugens and A. estronivorus MHB5 clusters (Figure 4).

3.2. Analysis of the EdcR Function

The edcR gene (EGO55_13520) has been annotated as a transcriptional regulator of the TetR family (Figure 2) according to pfam containing the characteristic domains of the proteins of this family [24,25], i.e., a DNA-binding domain (helix turn helix HTH, PF00440) and a C-terminal domain usually involved in inducer binding and protein oligomerization (domain TetR_C_11, PF16859).
The edc cluster of A. estronivorus MHB5 contains a MB02_RS00150 gene encoding a protein that shares 95% amino acid identity at the DNA binding domain (Figure 5) [14]. However, the product of the homologous KC8_05330 gene from Sphingomonas sp. KC8 shows only 53% amino acid identity at the DNA binding domain (Figure 5). This result suggests that the regulator of KC8 might recognize a different operator sequence and supports the exitance of conserved operator sequences in C. tardaugens and A. estronivorus.
To study the role of EdcR in the metabolism of E2 in C. tardaugens, we constructed a ∆edcR deletion mutant that was cultured it in minimal medium supplemented with E2 as the sole carbon and energy source. The ∆edcR strain is able to grow in E2 faster than the wild-type strain (Figure 6a), suggesting that EdcR is not an activator of E2 degradation. When the ∆edcR mutant was complemented with plasmid pSEVA23edcR expressing the gene edcR under the control of the PlexA constitutive promoter (Table 1), the recombinant strain grew slower than the ∆edcR mutant (Figure 6b), suggesting a probable repressor activity of the EdcR protein.
The influence of the absence of edcR on the expression of the genes of the edc cluster was determined using the ∆edcR mutant strain. Total RNA was extracted from the cells of wild-type and ∆edcR mutant strains growing in minimal medium with E2 or TES as the only carbon and energy sources, and RT-PCRs were performed to determine the relative expression of some representative genes of the edc cluster. EGO55_13555, EGO55_13570 and EGO55_13600 genes were chosen as representative markers of the expression of the OpA and OpB operons. The housekeeping recA gene (EGO55_01665) was used as internal control. As expected, the expression of the genes was detected in the presence of E2 in the wild-type and ∆edcR mutant strains (Figure 7). However, in the presence of TES the expression was only detected in the ∆edcR mutant strain (Figure 7). This result strongly reinforces the hypothesis that EdcR negatively regulates the expression of these edc genes and that the effector molecule could be E2 or some intermediate of the degradation pathway.

3.3. Analysis of the EdcR Effectors

As a tool to identify the effector of EdcR, we constructed transcriptional fusions using the gfp as a reporter gene in replicative plasmids. The Pa and Pb promoter regions were cloned in the plasmid pSEVA237 (Table 1). The cloned promoter regions comprise approximately 300 bp upstream from the ribosome binding site (RBS) of the EGO55_13565 and EGO55_13570 genes, respectively. The resulting plasmids, pSEVA237Pa (Figure S2) and pSEVA237Pb (Figure S3) were used to transform C. tardaugens wild type and ∆edcR mutant strains taking advantage that pSEVA237 is replicative in this strain. The resulting strains C. tardaugens (pSEVA237Pa), C. tardaugens (pSEVA237Pb), C. tardaugens ∆edcR (pSEVA237Pa) and C. tardaugens ∆edcR (pSEVA237Pb) were cultivated in NB rich medium supplemented with 2 mM E1 or with CDX as control, and the fluorescence was measured at 36 h. The experiment was carried out using E1 instead of E2, since E1 is the second metabolite of the E2 pathway (Figure 1), and we observed that the strain is also able to grow in E1 as the sole carbon and energy source, suggesting that E1 should act as an effector of the edc cluster. The fluorescence intensity in the wild-type strain increased in the presence of E1 but remained constant in the mutant strain (Figure 8). This result correlates with the previous observation that the expression in the wild strain is inducible while, as expected, the expression of gfp gene from the Pb and Pa promoters in the ∆edcR mutant is constitutive (Figure 8). This result confirmed that EdcR acts as a transcriptional repressor of OpA and OpB operons in C. tardaugens and that E1 or another intermediate metabolite of the pathway is capable of inducing the expression of the edc cluster.
To determine if E1 is the true inducer, and to exclude the possible implication of other intermediate metabolites produced further on the degradation pathway, we used the C. tardaugens ∆edcA strain, lacking the E1-hydroxylating activity that cannot transform E1 in other metabolites (Figure 1) [23]. It is worth mentioning here that the induction effect of E2 cannot be tested directly in C. tardaugens and although E2 is added as an inducer, we are testing the effect of E1, as E2 is transformed by the strain. C. tardaugens ∆edcA was cultured in minimal medium supplemented with TES as a carbon and energy source in the presence of E1, and total RNA was extracted. The expression of EGO55_13555, EGO55_13570 and EGO55_13600 genes was analyzed by RT-PCR. Figure 9 shows that the edc genes tested are induced in the presence of E1, suggesting that E1 acts as the true inducer of the edc cluster in C. tardaugens.

3.4. Analysis of the Promoters of the Edc Cluster in E. coli. Construction of an Estrogen Biosensor

To monitor the expression from the Pa and Pb promoters in a heterologous host, we used the pSEVA237Pa and pSEVA237Pb plasmids carrying the gfp gene under the control of Pa and Pb promoters, respectively, able to replicate in E. coli. The recombinant strains of E. coli DH10B (pSEVA237PlexA) (control plasmid), E. coli DH10B (pSEVA237Pa) and E. coli DH10B (pSEVA237Pb) were grown on LB and the fluorescence intensity of the cells were analyzed after 5 h. The fluorescence signal was only detected in E. coli DH10B (pSEVA237Pb), suggesting that only the Pb promoter is recognized by the E. coli RNA-polymerase (Figure S4).
To determine if EdcR can be a functional repressor of Pb promoter in E. coli, the edcR gene was cloned under the control of the PlexA promoter in the plasmid pSEVA651 (Table 1), generating the plasmid pSEVA65edcR. This plasmid was transformed in E. coli DH10B (pSEVA237Pb), generating the strain E. coli DH10B (pSEVA237Pb, pSEVA65edcR). E. coli DH10B (pSEVA237Pb, pSEVA651) carrying the empty vectors was used as a control. When the strains were grown in LB and the fluorescence intensity was measured after 5 h, we observed that the production of EdcR decreases the fluorescence intensity, suggesting that EdcR acts as a transcriptional repressor on the Pb promoter in E. coli (Figure 10).
To confirm that E1 is the true inducer of the edc cluster, we tested its effect in E. coli DH10B (pSEVA237Pb, pSEVA65edcR). A partial recovery of the fluorescence signal was observed in the presence of E1, indicating that E1 is also able to induce the expression of Pb promoter in E. coli (Figure 10). Interestingly, E2 had the same effect as E1, suggesting that E2 can be also recognized by EdcR as an inducer (Figure 10). A 2.9- and 2.6-fold increase in signal was observed when E1 and E2 inducers were used, respectively, compared to solvent control. As mentioned above, this induction effect of E2 could not be tested in C. tardaugens since a mutant unable to transform E2 into E1 is not available [22].
To test other possible inducers, these experiments were repeated using other steroids such as E3 and 4-OHE1, two natural estrogens that are known to be degraded by C. tardaugens; EE2, a synthetic estrogen that is not degraded by this strain; and TES, an androgen that does not induce the edc cluster and was used as a negative control. The results are shown in Figure 11 and confirmed that the EdcR only responds to E1 and E2.
Considering that this heterologous regulatory system responds specifically to the presence of estrogens, there is a possibility of developing a biosensor that could be applied to the detection of estrogens in the environment. For this purpose, a new transcriptional fusion of the Pb promoter was constructed using the plasmid pSEVA237M-BCD2-14g (Table 1). This plasmid includes a synthetic bicistronic RBS, BCD2, which increases translation by having two tandem ribosome-binding Shine–Dalgarno motifs [40] and a modified version of GFP, the monomeric superfolder green fluorescent protein, Msf-GFP, whose emission signal is more intense than that of GFP [41]. The synthetic promoter P14g of plasmid pSEVA237M-BCD2-14g was replaced by the Pb promoter and the resulting plasmid, pSEVA237MPb (Figure 12a), was transformed into E. coli DH10B, obtaining the strain E. coli DH10B (pSEVA237MPb).
This strain was transformed with the vector pSEVA65edcR, and the resulting strain, E. coli DH10B (pSEVA237MPb, pSEVA65edcR), was grown in the presence of E1 and E2. The reporter system responds to the presence of both compounds E1 and E2 (Figure 12c,d), and the signal registered was an order of magnitude higher than that obtained with E. coli DH10B (pSEVA237Pb, pSEVA65edcR) (Figure 10). The concentration of the inducer molecules E1 and E2 was increased to determine the response curve of the biosensor. The EC50 inferred from the resulting sigmoid functions was 3.32 μM for E2 and 1.38 μM for E1. The differences in the signal fluorescence intensity obtained in the presence or absence of the inducer molecules can be detected by the naked eye without the need for any special equipment (Figure 12e). Thus, the strain generated constitutes a good starting point for the construction of a more sensitive biosensor to determine the presence of estrogens in an environmental sample.

4. Discussion

The results presented above demonstrate that the edcR gene located contiguously to the edc cluster, responsible for E2 degradation, encodes a TetR-like regulator that represses the expression driven by the Pa and Pb promoters. These promoters control the expression OpA and OpB operons encoding the enzymes of the upper E2 degradation pathway. We have also shown that E2 and E1 act as true inducers of EdcR regulator. EdcR is a new member of a very short list of bacterial regulators that have been linked to the control of steroid degradative pathways. The best characterized regulators in this list are the KstR and KstR2 regulators that control the expression of the cholesterol upper and lower degradative pathway, respectively, in actinobacteria [42,43,44,45,46,47,48]. As EdcR, KstR and KstR2 are TetR-like repressors, KstR and KstR2 effector molecules have been identified being 3-oxocholest-4-en-26-oyl-CoA, a metabolite synthetized in the first steps of cholesterol degradation, and HIP-CoA, respectively [46,49,50]. Another example is provided by the regulators involved in TES degradation by Comamonas testosteroni, where, according to the published data, the regulation appears to be rather complex. A LuxR-type regulator (TeiR, Testosterone-inducible Regulator), which positively regulates TES degradation, was initially identified in this bacterium [51,52,53]. This positive regulation appears to require a metabolite derived from TES degradation. A tesR gene almost identical to teiR was also identified in C. testosteroni TA441 [54]. TeiR regulator was shown to be a kinase that responds to a variety of different steroids other than TES, and also mediated the induced expression of 3α-hydroxysteroid dehydrogenase/carbonyl reductase involved in TES metabolism, encoded by the hsdA gene [55]. Nevertheless, the regulation of hsdA expression is even more complex since two repressors, RepA and RepB [56,57], along with HsdR, a LysR-like regulator [58], are also involved. On the other hand, a LuxR-like regulator has been described as a repressor that controls the expression of 3,17β-hydroxysteroid dehydrogenase [59,60]. In this case, TES appears to be the inducer [60]. Other works have identified in C. testosteroni a TetR-like regulator, controlling the expression of 3,17β-hydroxysteroid dehydrogenase [61,62,63]. Regarding the regulation of the 4,5-seco pathway of steroid degradation, there is only one previous study identifying CrgA and OxyR acting as an activator and a repressor, respectively, of the expression of a 17β-HSDs capable of transforming E2 into E1 in P. putida SJTE-1 [19]. HSDs are widely distributed in steroid-degrading bacteria and often present a wide range of substrates, catalyzing reactions in a nonspecific manner [22,64], and the regulation of other HSDs involved in testosterone degradation has been extensively studied [56,57,59,61,62,63,65]. In this regard, the new information gathered in this work becomes of great importance, as it is the first time that the regulation of a cluster essential for estrogen degradation, which contains the specific genes required for the cleavage of the core of the molecule, has been addressed. Furthermore, it is the first time that the participation of a regulator of the TetR family in estrogen metabolism in bacteria has been demonstrated.
In silico analysis of estrogen degradation clusters from different bacteria revealed the existence of proteins homologous to EdcR (EGO55_13520) of C. tardaugens, encoded by genes MB02_RS00150, F7P65_RS09285, KC8_05330 and IM701_20395 from A. estronivorus MH-B5 (Qin et al., 2016), S. estronivorans AXB (Qin et al., 2020), Sphingomonas sp. KC8 (Chen et al., 2017) and Novosphingobium ES2-1 (Li et al., 2020), respectively. Interestingly, the palindromic sequence found overlapping the -10 box in Pa and Pb promoters of C. tardaugens is entirely conserved in the Pa- and Pb-equivalent promoter regions of A. estronivorus. Negative autoregulation is a common feature of gene regulation [66] and in examples described in steroid metabolism, the palindromic operator sequence has been found in front of the regulatory gene itself, such as in KstR and HsdR [42,65]. The proposed EdcR operator palindrome (TnnCnnTACnAnTnGTAnnGnnA) is only partially conserved in Pr, (TnnCnnTAnnAnTnnTAnnGnnA), suggesting that EdcR would repress its own expression, but likely less efficiently. Although previous studies showed that the identification of repeated sequences does not guarantee that they are the operating regions recognized by the corresponding TetR regulator [25], this approach has been successfully applied in some cases [67]. In addition, HTH DNA-binding domains of EdcR and its homolog in A. estronivorus share a high percentage of amino acid sequence identity, which is a characteristic observed, in general, within the TetR family proteins, where the HTH DNA-binding domain is more conserved than the substrate-binding domain [24]. This evidence suggests the existence of a conserved estrogen degradation regulatory system in these two bacteria. However, this conservation cannot be extended to the intergenic regions of Sphingomonas sp. KC8 and Sphingobium estronivorans AXB, where in silico analysis did not reveal the presence of the palindromic sequence. Other bacteria described as estrogen degrading with genomes available in databases, such as Achromobacter xylosoxidans NBRC 15,126 (accession number NZ_BCZG01000023.1) and Denitratisoma oestradiolicum DSM 16959(T) (accession number NZ_LR778301.1) do not have a regulatory gene similar to EdcR and have a very different organization of the estrogen degradation cluster than in C. tardaugens. Although homologous proteins to EdcR have been found in the genomes of these bacteria, the protein encoded by AX2_RS23365 in A. xylosoxidans NBRC 15,126 presents 79% ID with 30.36% coverage, but with very low statistical significance (2E-05), whereas the proteins encoded by DENOEST_RS05595 and DENOEST_RS05530 in D. oestradiolicum DSM 16959(T) present 79% and 91% ID with 38.18% and 35.26% coverage and with statistical significance of 2 × 10−28 and 4 × 10−27, respectively. The edc cluster is not present in the estrogen degrading bacteria Steroidobacter denitrificans FST, as it metabolizes them under anaerobic conditions, involving a distinct set of genes [68]. There are other bacteria (belonging to different genera) having homologous to EdcR but their estrogen-degrading capacity has not been described.
In this work, we also investigated the expression of the EdcR regulatory system from C. tardaugens in a heterologous host such as E. coli using the pSEVA plasmid platform. Only the Pb promoter that expresses the genes of OpB operon showed a significant activity in E. coli. As the transcriptional fusion of the Pa with the gfp gene showed a high activity in C. tardaugens, the lack of activity in E. coli cannot be ascribed to an incorrect construction. The Pb promoter region shows -35 and -10 boxes more similar to the consensus boxes of E. coli than the Pa promoter region that might not allow the E. coli RNA polymerase binding. The non-functionality of the Pa promoter in E. coli might suggest that a specific transcription factor not produced by E. coli is required in C. tardaugens to express the genes of OpA operon. The expression levels of different transcription factors were analyzed in the transcriptome of C. tardaugens cells growing in E2 [23]; however, none of them showed any induction correlating with that observed in genes of the edc cluster.
The construction of the heterologous regulatory system in E. coli has allowed identifying E2, in addition to E1, as effectors of EdcR. Due to the high redundancy of 17β-hydroxysteroid dehydrogenase activities in C. tardaugens [22], a mutant unable to transform E2 into E1 is not available and thus, it was impossible to distinguish in C. tardaugens the induction effect of E2 and E1, since E2 is immediately converted into E1. Moreover, the E. coli heterologous systems have opened the possibility to explore them as biosensor chassis to detect estrogen in environmental samples. In this chassis, the mechanisms of TetR-like regulators as well as the wide variety of inducer compounds have been extensively studied [24,25], and several of them have been used to construct biosensors so far [69,70,71,72,73,74,75].
The detection of EDCs is currently carried out by chromatographic analysis [76,77]. Nevertheless, several biosensors have also been developed to detect EDCs. These biosensors are mainly based on antibodies [78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100], aptamers [101,102,103,104,105,106,107,108,109] and the isolated animal estrogen α-receptor (ERα) [93,110,111,112,113,114,115], or integrated in bacteria [116,117,118], fungi [119], yeast [120,121,122], eukaryotic cell lines [123,124,125], plants [126] or transgenic animals [127,128,129,130,131,132,133,134,135,136]. Only a few examples of bacterial biosensors based on specific bacterial regulatory systems useful to detect steroids have been described so far. For instance, taking advantage that the expression of the hsdA gene from C. testosteroni is regulated by different steroids [137], a C. testosteroni mutant harboring a hsdA-gfp transcriptional fusion has been created to detect the presence of TES, E2 and cholesterol in a competitive manner when compared to other biosensors [138]. More recently, an optical progesterone biosensor was created based on the use of a TetR-like transcription factor named SRTF1 of Pimelobacter simplex [139].
In this work, we developed four biosensors based on the use of different recombinant cells: (i) C. tardaugens (pSEVA237Pb), (ii) C. tardaugens (pSEVA237Pa), (iii) E. coli (pSEVA237Pb, pSEVA65edcR) and (iv) E. coli (pSEVA237MPb, pSEVA65edcR). The last one allows the detection of the pollutants by the naked eye. Most important is the fact that once the components of the system (regulator, effectors, promoters and operator sequence) are identified, it is possible to improve the sensitivity and the specificity of the system by using different genetic engineering tools. For instance, the EdcR regulator can be engineered to recognize a wider range of effectors or to improve the binding constant the cognate inducers. Promoter and operator sequences can be optimized, and the whole system can be tuned to find the highest sensitivity. EdcR could be used as SRTF1 from P. simplex to develop optical biosensors. Additionally, other bacteria different from E. coli (e.g., P. putida) that could uptake the estrogens more efficiently can be considered as possible chassis to support the biosensor. Finally, the results of this work pave the way to develop new regulatory circuits involving EdcR and specific estrogenic effectors that can be useful for different biotechnological purposes.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/genes12121846/s1, Table S1: Primers used in this study. Restriction enzymes used for cloning are shown in brackets. Figure S1. Nucleotide sequence of pSEVA237MPb. Hybridation sequences of oligonucleotides used to clone Pb into pSEV237 backbone are underlined. Scars left after ligation of Pb promoter fragment into pSEVA237M-BCD2 backbone are shown in bold. The synthetic bicistronic RBS, BCD2, is shown in italics. Figure S2. Nucleotide sequence of pSEVA237Pa. Hybridation sequences of oligonucleotides used to clone Pa into pSEVA237 backbone are underlined and restriction enzyme sites are shown in bold. Figure S3. Nucleotide sequence of pSEVA237Pb. Hybridation sequences of oligonucleotides used to clone Pb into pSEV237 backbone are underlined and restriction enzyme sites are shown in bold. Figure S4. Fluorescence intensity of the E. coli DH10B (pSEVA23PlexA) as control, E. coli DH10B (pSEVA237Pa) and E. coli DH10B (pSEVA237Pb) strains carrying the transcriptional fusions of the Pa, Pb and Pt promoter regions, respectively. The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.

Author Contributions

J.I. carried out molecular genetic studies, in silico analysis, fermentation experiments and helped to draft the manuscript. J.L.G. conceived the study. J.L.G. and B.G. coordinated the study and drafted the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ramón Areces Foundation.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The bioinformatics support of the Bioinformatics and Biostatistics Service of CIB, particularly Guillermo Padilla Alonso, is greatly appreciated. We also acknowledge the financial support provided by the Ramón Areces Foundation.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Santos, L.H.M.L.M.; Araújo, A.N.; Fachini, A.; Pena, A.; Delerue-Matos, C.; Montenegro, M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175, 45–95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Fan, Z.; Casey, F.X.M.; Hakk, H.; Larsen, G.L. Persistence and fate of 17β-estradiol and testosterone in agricultural soils. Chemosphere 2007, 67, 886–895. [Google Scholar] [CrossRef] [PubMed]
  3. Bradley, P.M.; Chapelle, F.H.; Barber, L.B.; McMahon, P.B.; Gray, J.L.; Kolpin, D.W. Biodegradation of 17β-estradiol, estrone, and testosterone in stream sediments. Environ. Sci. Technol. 2009, 43, 1902–1910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Fan, Z.; Wu, S.; Chang, H.; Hu, J. Behaviors of glucocorticoids, androgens and progestogens in a municipal sewage treatment plant: Comparison to estrogens. Environ. Sci. Technol. 2011, 45, 2725–2733. [Google Scholar] [CrossRef]
  5. Fujii, K.; Kikuchi, S.; Satomi, M.; Ushio-Sata, N.; Morita, N. Degradation of 17β-estradiol by a gram-negative bacterium isolated from activated sludge in a sewage treatment plant in Tokyo, Japan. Appl. Environ. Microbiol. 2002, 68, 2057–2060. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Fahrbach, M.; Kuever, J.; Meinke, R.; Kampfer, P.; Hollender, J. Denitratisoma oestradiolicum gen. nov., sp. nov., a 17beta-oestradiol-degrading, denitrifying betaproteobacterium. Int. J. Syst. Evol. Microbiol. 2006, 56, 1547–1552. [Google Scholar] [CrossRef] [Green Version]
  7. Yu, C.-P.; Roh, H.; Chu, K.-H. 17β-estradiol-degrading bacteria isolated from activated sludge. Environ. Sci. Technol. 2007, 41, 486–492. [Google Scholar] [CrossRef] [PubMed]
  8. Yu, Q.; Wang, P.; Liu, D.; Gao, R.; Shao, H.; Zhao, H.; Ma, Z.; Wang, D.; Huo, H. Degradation characteristics and metabolic pathway of 17β-estradiol (E2) by Rhodococcus sp. DS201. Biotechnol. Bioprocess Eng. 2016, 21, 804–813. [Google Scholar] [CrossRef]
  9. Kurisu, F.; Ogura, M.; Saitoh, S.; Yamazoe, A.; Yagi, O. Degradation of natural estrogen and identification of the metabolites produced by soil isolates of Rhodococcus sp. and Sphingomonas sp. J. Biosci. Bioeng. 2010, 109, 576–582. [Google Scholar] [CrossRef]
  10. Chen, Y.L.; Yu, C.P.; Lee, T.H.; Goh, K.S.; Chu, K.H.; Wang, P.H.; Ismail, W.; Shih, C.J.; Chiang, Y.R. Biochemical mechanisms and catabolic enzymes involved in bacterial estrogen degradation pathways. Cell Chem. Biol. 2017, 24, 712–724.e7. [Google Scholar] [CrossRef] [Green Version]
  11. Wang, P.; Zheng, D.; Liang, R. Isolation and characterization of an estrogen-degrading Pseudomonas putida strain SJTE-1. 3 Biotech 2019, 9, 61. [Google Scholar] [CrossRef] [PubMed]
  12. Li, S.; Liu, J.; Williams, M.A.; Ling, W.; Sun, K.; Lu, C.; Gao, Y.; Waigi, M.G. Metabolism of 17β-estradiol by Novosphingobium sp. ES2-1 as probed via HRMS combined with 13C3-labeling. J. Hazard. Mater. 2020, 389, 121875. [Google Scholar] [CrossRef]
  13. Qin, D.; Ma, C.; Lv, M.; Yu, C.-P. Sphingobium estronivorans sp. nov. and Sphingobium bisphenolivorans sp. nov., isolated from a wastewater treatment plant. Int. J. Syst. Evol. Microbiol 2020, 70, 1822–1829. [Google Scholar] [CrossRef] [PubMed]
  14. Qin, D.; Ma, C.; Hu, A.; Zhang, F.; Hu, H.; Yu, C.P. Altererythrobacter estronivorus sp. nov., an estrogen-degrading strain isolated from Yundang Lagoon of Xiamen City in China. Curr. Microbiol. 2016, 72, 634–640. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, P.H.; Chen, Y.L.; Wei, S.T.S.; Wu, K.; Lee, T.H.; Wu, T.Y.; Chiang, Y.R. Retroconversion of estrogens into androgens by bacteria via a cobalamin-mediated methylation. Proc. Natl. Acad. Sci. USA 2020, 117, 1395–1403. [Google Scholar] [CrossRef]
  16. Yu, C.P.; Deeb, R.A.; Chu, K.H. Microbial degradation of steroidal estrogens. Chemosphere 2013, 91, 1225–1235. [Google Scholar] [CrossRef]
  17. Wang, P.H.; Yu, C.P.; Lee, T.H.; Lin, C.W.; Ismail, W.; Wey, S.P.; Kuo, A.T.; Chiang, Y.R. Anoxic androgen degradation by the denitrifying bacterium Sterolibacterium denitrificans via the 2,3-seco pathway. Appl. Environ. Microbiol. 2014, 80, 3442–3452. [Google Scholar] [CrossRef] [Green Version]
  18. Wang, P.; Zheng, D.; Wang, Y.; Liang, R. One 3-oxoacyl-(acyl-Carrier-protein) reductase functions as 17β-hydroxysteroid dehydrogenase in the estrogen-degrading Pseudomonas putida SJTE-1. Biochem. Biophys. Res. Commun. 2018, 505, 910–916. [Google Scholar] [CrossRef]
  19. Wang, P.; Zheng, D.; Peng, W.; Wang, Y.; Wang, X.; Xiong, W.; Liang, R. Characterization of 17β-hydroxysteroid dehydrogenase and regulators involved in estrogen degradation in Pseudomonas putida SJTE-1. Appl. Microbiol. Biotechnol. 2019, 103, 2413–2425. [Google Scholar] [CrossRef]
  20. Fujii, K.; Satomi, M.; Morita, N.; Motomura, T.; Tanaka, T.; Kikuchi, S. Novosphingobium tardaugens sp. nov., an oestradiol-degrading bacterium isolated from activated sludge of a sewage treatment plant in Tokyo. Int. J. Syst. Evol. Microbiol. 2003, 53, 47–52. [Google Scholar] [CrossRef] [Green Version]
  21. Ibero, J.; Sanz, D.; Galán, B.; Díaz, E.; JL, G. High-quality whole-genome sequence of an estradiol-degrading strain, Novosphingobium tardaugens NBRC 16725. Microb. Resour. Annoucements 2019, 8, e01715-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Ibero, J.; Galán, B.; Díaz, E.; García, J.L. Testosterone degradative pathway of Novosphingobium tardaugens. Genes 2019, 10, 871. [Google Scholar] [CrossRef] [Green Version]
  23. Ibero, J.; Galán, B.; Rivero-Buceta, V.; García, J.L. Unraveling the 17β-estradiol degradation pathway in Novosphingobium tardaugens NBRC 16725. Front. Microbiol. 2020, 11, 588300. [Google Scholar] [CrossRef] [PubMed]
  24. Ramos, J.L.; Martínez-Bueno, M.; Molina-Henares, A.J.; Terán, W.; Watanabe, K.; Zhang, X.; Gallegos, M.T.; Brennan, R.; Tobes, R. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 2005, 69, 326–356. [Google Scholar] [CrossRef] [Green Version]
  25. Cuthbertson, L.; Nodwell, J.R. The TetR family of regulators. Microbiol. Mol. Biol. Rev. 2013, 77, 440–475. [Google Scholar] [CrossRef] [Green Version]
  26. Bertani, G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 1951, 62, 293–300. [Google Scholar] [CrossRef] [Green Version]
  27. Sambrook, J.; Russell, D.W. Molecular Cloning: A Laboratory Manual, 3rd ed.; Cold Spring Harbor Laboratory Press: New York, NY, USA, 2001. [Google Scholar]
  28. Schafer, A.; Tauch, A.; Jager, W.; Kalinowski, J.; Thierbach, G.; Puhler, A. Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: Selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene 1994, 145, 69–73. [Google Scholar] [CrossRef]
  29. Fernández, H.; Prandoni, N.; Fernández-Pascual, M.; Fajardo, S.; Morcillo, C.; Díaz, E.; Carmona, M. Azoarcus sp. CIB, an anaerobic biodegrader of aromatic compounds shows an endophytic lifestyle. PLoS ONE 2014, 9, e110771. [Google Scholar] [CrossRef]
  30. Silva-Rocha, R.; Martínez-García, E.; Calles, B.; Chavarría, M.; Arce-Rodríguez, A.; De Las Heras, A.; Páez-Espino, A.D.; Durante-Rodríguez, G.; Kim, J.; Nikel, P.I.; et al. The Standard European Vector Architecture (SEVA): A coherent platform for the analysis and deployment of complex prokaryotic phenotypes. Nucleic Acids Res. 2013, 41, D666–D675. [Google Scholar] [CrossRef]
  31. Wirth, R.; Friesenegger, A.; Fiedler, S. Transformation of various species of gram-negative bacteria belonging to 11 different genera by electroporation. Mol. Gen. Genet. MGG 1989, 216, 175–177. [Google Scholar] [CrossRef]
  32. Herrero, M.; De Lorenzo, V.; Timmis, K.N. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J. Bacteriol. 1990, 172, 6557–6567. [Google Scholar] [CrossRef] [Green Version]
  33. Sharma, S.B.; Signer, E.R. Temporal and spatial regulation of the symbiotic genes of Rhizobium meliloti in planta revealed by transposon Tn5-gusA. Genes Dev. 1990, 4, 344–356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Solovyev, V.; Salamov, A. Automatic annotation of microbial genomes and metagenomic sequences. Metagenomics Appl. Agric. Biomed. Environ. Stud. 2011, 62–78. [Google Scholar]
  35. Coppens, L.; Lavigne, R. SAPPHIRE: A neural network based classifier for σ70 promoter prediction in Pseudomonas. BMC Bioinform. 2020, 21, 415. [Google Scholar] [CrossRef] [PubMed]
  36. Aziz, R.K.; Bartels, D.; Best, A.; DeJongh, M.; Disz, T.; Edwards, R.A.; Formsma, K.; Gerdes, S.; Glass, E.M.; Kubal, M.; et al. The RAST Server: Rapid annotations using subsystems technology. BMC Genom. 2008, 9, 75. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215, 403–410. [Google Scholar] [CrossRef]
  38. Abio Madeira, F.; Mi Park, Y.; Lee, J.; Buso, N.; Gur, T.; Madhusoodanan, N.; Basutkar, P.; Tivey, A.R.N.; Potter, S.C.; Finn, R.D.; et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 2019, 47, W636–W641. [Google Scholar] [CrossRef] [Green Version]
  39. Rosenberg, M.; Court, D. Regulatory sequences involved in the promotion and termination of RNA transcription. Annu. Rev. Genet. 1979, 13, 319–353. [Google Scholar] [CrossRef]
  40. Mutalik, V.K.; Guimaraes, J.C.; Cambray, G.; Lam, C.; Christoffersen, M.J.; Mai, Q.A.; Tran, A.B.; Paull, M.; Keasling, J.D.; Arkin, A.P.; et al. Precise and reliable gene expression via standard transcription and translation initiation elements. Nat. Methods 2013, 10, 354–360. [Google Scholar] [CrossRef]
  41. Landgraf, D. Quantifying Localizations and Dynamics in Single Bacterial Cells. Ph.D. Thesis, Harvard University, Cambridge, UK, 2012. [Google Scholar]
  42. Kendall, S.L.; Withers, M.; Soffair, C.N.; Moreland, N.J.; Gurcha, S.; Sidders, B.; Frita, R.; Ten Bokum, A.; Besra, G.S.; Lott, J.S.; et al. A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. Mol. Microbiol. 2007, 65, 684–699. [Google Scholar] [CrossRef] [Green Version]
  43. Uhía, I.; Galán, B.; Kendall, S.L.; Stoker, N.G.; García, J.L. Cholesterol metabolism in Mycobacterium smegmatis. Environ. Microbiol. Rep. 2012, 4, 168–182. [Google Scholar] [CrossRef]
  44. Uhía, I.; Galán, B.; Medrano, F.J.; García, J.L. Characterization of the KstR-dependent promoter of the gene for the first step of the cholesterol degradative pathway in Mycobacterium smegmatis. Microbiology 2011, 157, 2670–2680. [Google Scholar] [CrossRef] [PubMed]
  45. García-Fernández, E.; Medrano, F.J.; Galán, B.; García, J.L. Deciphering the transcriptional regulation of cholesterol catabolic pathway in mycobacteria: Identification of the inducer of KstR repressor. J. Biol. Chem. 2014, 289, 17576–17588. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. García-Fernández, J.; Galán, B.; Medrano, F.J.; García, J.L. Characterization of the KstR2 regulator responsible of the lower cholesterol degradative pathway in Mycobacterium smegmatis. Environ. Microbiol. Rep. 2015, 7, 155–163. [Google Scholar] [CrossRef] [Green Version]
  47. Kendall, S.L.; Burgess, P.; Balhana, R.; Withers, M.; Ten Bokum, A.; Lott, J.S.; Gao, C.; Uhia-Castro, I.; Stoker, N.G. Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2. Microbiology 2010, 156, 1362–1371. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Van Der Geize, R.; Yam, K.; Heuser, T.; Wilbrink, M.H.; Hara, H.; Anderton, M.C.; Sim, E.; Dijkhuizen, L.; Davies, J.E.; Mohn, W.W.; et al. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc. Natl. Acad. Sci. USA 2007, 104, 1947–1952. [Google Scholar] [CrossRef] [Green Version]
  49. Ding, J.Y.; Shiu, J.H.; Chen, W.M.; Chiang, Y.R.; Tang, S.L. Genomic insight into the host-endosymbiont relationship of Endozoicomonas montiporae CL-33T with its coral host. Front. Microbiol. 2016, 7, 251. [Google Scholar] [CrossRef] [Green Version]
  50. Casabon, I.; Zhu, S.H.; Otani, H.; Liu, J.; Mohn, W.W.; Eltis, L.D. Regulation of the KstR2 regulon of Mycobacterium tuberculosis by a cholesterol catabolite. Mol. Microbiol. 2013, 89, 1201–1212. [Google Scholar] [CrossRef]
  51. Linares, M.; Pruneda-Paz, J.L.; Reyna, L.; Genti-Raimondi, S. Regulation of testosterone degradation in Comamonas testosteroni. J. Steroid Biochem. Mol. Biol. 2008, 112, 145–150. [Google Scholar] [CrossRef]
  52. Pruneda-Paz, J.L.; Linares, M.; Cabrera, J.E.; Genti-Raimondi, S. Identification of a novel steroid inducible gene associated with the βhsd locus of Comamonas testosteroni. J. Steroid Biochem. Mol. Biol. 2004, 88, 91–100. [Google Scholar] [CrossRef]
  53. Pruneda-Paz, J.L.; Linares, M.; Cabrera, J.E.; Genti-Raimondi, S. TeiR, a LuxR-type transcription factor required for testosterone degradation in Comamonas testosteroni. J. Bacteriol. 2004, 186, 1430–1437. [Google Scholar] [CrossRef] [Green Version]
  54. Horinouchi, M.; Kurita, T.; Yamamoto, T.; Hatori, E.; Hayashi, T.; Kudo, T. Steroid degradation gene cluster of Comamonas testosteroni consisting of 18 putative genes from meta-cleavage enzyme gene tesB to regulator gene tesR. Biochem. Biophys. Res. Commun. 2004, 324, 597–604. [Google Scholar] [CrossRef]
  55. Göhler, A.; Xiong, G.; Paulsen, S.; Trentmann, G.; Maser, E. Testosterone-inducible regulator is a kinase that drives steroid sensing and metabolism in Comamonas testosteroni. J. Biol. Chem. 2008, 283, 17380–17390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Xiong, G.; Maser, E. Regulation of the steroid-inducible 3α-hydroxysteroid dehydrogenase/carbonyl reductase gene in Comamonas testosteroni. J. Biol. Chem. 2001, 276, 9961–9970. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Xiong, G.; Martin, H.J.; Maser, E. Identification and characterization of a novel translational repressor of the steroid-inducible 3α-hydroxysteroid dehydrogenase/carbonyl reductase gene in Comamonas testosteroni. J. Biol. Chem. 2003, 278, 47400–47407. [Google Scholar] [CrossRef] [Green Version]
  58. Gong, W.; Xiong, G.; Maser, E. Identification and characterization of the LysR-type transcriptional regulator HsdR for steroid-inducible expression of the 3α-hydroxysteroid dehydrogenase/carbonyl reductase gene in Comamonas testosteroni. Appl. Environ. Microbiol. 2012, 78, 941–950. [Google Scholar] [CrossRef] [Green Version]
  59. Ji, Y.; Pan, T.; Zhang, Y.; Xiong, G.; Yu, Y. Functional analysis of a novel repressor LuxR in Comamonas testosteroni. Chem. Biol. Interact. 2017, 276, 113–120. [Google Scholar] [CrossRef] [PubMed]
  60. Ji, Y.; Yang, J.; Gao, L.; Xiong, G.; Yu, Y.; Zhang, Y. Characterization of a LuxR repressor for 3,17β-HSD in Comamonas testosteroni ATCC11996. Chem. Biol. Interact. 2021, 336, 109271. [Google Scholar] [CrossRef] [PubMed]
  61. Li, M.; Xiong, G.; Maser, E. A novel transcriptional repressor PhaR for the steroid-inducible expression of the 3,17β-hydroxysteroid dehydrogenase gene in Comamonas testosteroni ATCC 11996. In Proceedings of the Chemico-Biological Interactions; Elsevier: Amsterdam, The Netherlands, 2013; Volume 202, pp. 116–125. [Google Scholar]
  62. Pan, T.; Huang, P.; Xiong, G.; Maser, E. Isolation and identification of a repressor TetR for 3,17β-HSD expressional regulation in Comamonas testosteroni. Chem. Biol. Interact. 2015, 234, 205–212. [Google Scholar] [CrossRef]
  63. Wu, Y.; Huang, P.; Xiong, G.; Maser, E. Identification and isolation of a regulator protein for 3,17β-HSD expressional regulation in Comamonas testosteroni. Chem. Biol. Interact. 2015, 234, 197–204. [Google Scholar] [CrossRef]
  64. Gong, W.; Xiong, G.; Maser, E. Cloning, expression and characterization of a novel short-chain dehydrogenase/reductase (SDRx) in Comamonas testosteroni. J. Steroid Biochem. Mol. Biol. 2012, 129, 15–21. [Google Scholar] [CrossRef]
  65. Gong, W.; Xiong, G.; Maser, E. Oligomerization and negative autoregulation of the LysR-type transcriptional regulator HsdR from Comamonas testosteroni. J. Steroid Biochem. Mol. Biol. 2012, 132, 203–211. [Google Scholar] [CrossRef] [PubMed]
  66. Shen-Orr, S.S.; Milo, R.; Mangan, S.; Alon, U. Network motifs in the transcriptional regulation network of Escherichia coli. Nat. Genet. 2002, 31, 64–68. [Google Scholar] [CrossRef] [PubMed]
  67. Yu, Z.; Reichheld, S.E.; Savchenko, A.; Parkinson, J.; Davidson, A.R. A comprehensive analysis of structural and sequence conservation in the TetR family transcriptional regulators. J. Mol. Biol. 2010, 400, 847–864. [Google Scholar] [CrossRef] [PubMed]
  68. Fahrbach, M.; Kuever, J.; Remesch, M.; Huber, B.E.; Kämpfer, P.; Dott, W.; Hollender, J. Steroidobacter denitrificans gen. nov., sp. nov., a steroidal hormone-degrading gammaproteobacterium. Int. J. Syst. Evol. Microbiol. 2008, 58, 2215–2223. [Google Scholar] [CrossRef] [Green Version]
  69. Bertram, R.; Hillen, W. The application of Tet repressor in prokaryotic gene regulation and expression. Microb. Biotechnol. 2008, 1, 2–16. [Google Scholar] [CrossRef] [PubMed]
  70. Zhang, J.; Wang, Z.; Su, T.; Sun, H.; Zhu, Y.; Qi, Q.; Wang, Q. Tuning the binding affinity of heme-responsive biosensor for precise and dynamic pathway regulation. iScience 2020, 23, 101067. [Google Scholar] [CrossRef]
  71. Galluzzi, L.; Virtanen, P.; Karp, M. A real-time analysis of QacR-regulated multidrug resistance in Staphylococcus aureus. Biochem. Biophys. Res. Commun. 2003, 301, 24–30. [Google Scholar] [CrossRef]
  72. Xiong, D.; Lu, S.; Wu, J.; Liang, C.; Wang, W.; Wang, W.; Jin, J.M.; Tang, S.Y. Improving key enzyme activity in phenylpropanoid pathway with a designed biosensor. Metab. Eng. 2017, 40, 115–123. [Google Scholar] [CrossRef]
  73. Tahlan, K.; Ahn, S.K.; Sing, A.; Bodnaruk, T.D.; Willems, A.R.; Davidson, A.R.; Nodwell, J.R. Initiation of actinorhodin export in Streptomyces coelicolor. Mol. Microbiol. 2007, 63, 951–961. [Google Scholar] [CrossRef]
  74. Espinosa-Urgel, M.; Serrano, L.; Ramos, J.L.; Fernández-Escamilla, A.M. Engineering biological approaches for detection of toxic compounds: A new microbial biosensor based on the Pseudomonas putida TtgR repressor. Mol. Biotechnol. 2015, 57, 558–564. [Google Scholar] [CrossRef] [PubMed]
  75. Chen, W.; Zhang, X.; Xiong, D.; Jin, J.M.; Tang, S.Y. Engineering the effector specificity of regulatory proteins for the in vitro detection of biomarkers and pesticide residues. Appl. Microbiol. Biotechnol. 2019, 103, 3205–3213. [Google Scholar] [CrossRef]
  76. Rodriguez-Mozaz, S.; Lopez De Alda, M.J.; Barceló, D. Picogram per liter level determination of estrogens in natural waters and waterworks by a fully automated on-line solid-phase extraction-liquid chromatography-electrospray tandem mass spectrometry method. Anal. Chem. 2005, 76, 6998–7006. [Google Scholar] [CrossRef] [PubMed]
  77. Rodriguez-Mozaz, S.; Lopez de Alda, M.J.; Barceló, D. Advantages and limitations of on-line solid phase extraction coupled to liquid chromatography-mass spectrometry technologies versus biosensors for monitoring of emerging contaminants in water. J. Chromatogr. A 2007, 1152, 97–115. [Google Scholar] [CrossRef] [PubMed]
  78. Padeste, C.; Grubelnik, A.; Tiefenauer, L. Amperometric immunosensing using microperoxidase MP-11 antibody conjugates. Anal. Chim. Acta 1998, 374, 167–176. [Google Scholar] [CrossRef]
  79. Sesay, A.M.; Cullen, D.C. Detection of hormone mimics in water using a miniturised SPR sensor. Environ. Monit. Assess. 2001, 70, 83–92. [Google Scholar] [CrossRef]
  80. Sun, M.; Du, L.; Gao, S.; Bao, Y.; Wang, S. Determination of 17β-oestradiol by fluorescence immunoassay with streptavidin-conjugated quantum dots as label. Steroids 2010, 75, 400–403. [Google Scholar] [CrossRef]
  81. Liu, X.; Wang, X.; Zhang, J.; Feng, H.; Liu, X.; Wong, D.K.Y. Detection of estradiol at an electrochemical immunosensor with a Cu UPD|DTBP-Protein G scaffold. Biosens. Bioelectron. 2012, 35, 56–62. [Google Scholar] [CrossRef] [PubMed]
  82. Ojeda, I.; López-Montero, J.; Moreno-Guzmán, M.; Janegitz, B.C.; González-Cortés, A.; Yáñez-Sedeño, P.; Pingarrón, J.M. Electrochemical immunosensor for rapid and sensitive determination of estradiol. Anal. Chim. Acta 2012, 743, 117–124. [Google Scholar] [CrossRef] [PubMed]
  83. Zhang, S.; Du, B.; Li, H.; Xin, X.; Ma, H.; Wu, D.; Yan, L.; Wei, Q. Metal ions-based immunosensor for simultaneous determination of estradiol and diethylstilbestrol. Biosens. Bioelectron. 2014, 52, 225–231. [Google Scholar] [CrossRef]
  84. Tomizawa, S.; Chuah, J.A.; Matsumoto, K.; Doi, Y.; Numata, K. Understanding the limitations in the biosynthesis of polyhydroxyalkanoate (PHA) from lignin derivatives. ACS Sustain. Chem. Eng. 2014, 2, 1106–1113. [Google Scholar] [CrossRef]
  85. Monerris, M.J.; Arévalo, F.J.; Fernández, H.; Zon, M.A.; Molina, P.G. Development of a very sensitive electrochemical immunosensor for the determination of 17β-estradiol in bovine serum samples. Sens. Actuators B Chem. 2015, 208, 525–531. [Google Scholar] [CrossRef]
  86. Du, L.; Ji, W.; Zhang, Y.; Zhang, C.; Liu, G.; Wang, S. Ultrasensitive detection of 17β-estradiol using gold nanoparticle-based fluorescence immunoassay. J. Mater. Chem. C 2015, 3, 10715–10722. [Google Scholar] [CrossRef] [PubMed]
  87. Piro, B.; Shi, S.; Reisberg, S.; Noël, V.; Anquetin, G. Comparison of electrochemical immunosensors and aptasensors for detection of small organic molecules in environment, food safety, clinical and public security. Biosensors 2016, 6, 7. [Google Scholar] [CrossRef] [Green Version]
  88. Wang, S.; Zhuang, H.; Du, L.; Lin, S.; Wang, C. Determination of estradiol by biotin-avidin-amplified electrochemical enzyme immunoassay. Anal. Lett. 2007, 40, 887–896. [Google Scholar] [CrossRef]
  89. Xin, T.B.; Chen, H.; Lin, Z.; Liang, S.X.; Lin, J.M. A secondary antibody format chemiluminescence immunoassay for the determination of estradiol in human serum. Talanta 2010, 82, 1472–1477. [Google Scholar] [CrossRef]
  90. Kuramitz, H.; Matsuda, M.; Thomas, J.H.; Sugawara, K.; Tanaka, S. Electrochemical immunoassay at a 17β-estradiol self-assembled monolayer electrode using a redox marker. Analyst 2003, 128, 182–186. [Google Scholar] [CrossRef]
  91. Wang, S.; Lin, S.; Du, L.; Zhuang, H. Flow injection chemiluminescence immunoassay for 17β-estradiol using an immunoaffinity column. Anal. Bioanal. Chem. 2006, 384, 1186–1190. [Google Scholar] [CrossRef]
  92. Seifert, M. Luminescent enzyme-linked receptor assay for estrogenic compounds. Anal. Bioanal. Chem. 2004, 378, 684–687. [Google Scholar] [CrossRef]
  93. Habauzit, D.; Chopineau, J.; Roig, B. SPR-based biosensors: A tool for biodetection of hormonal compounds. Anal. Bioanal. Chem. 2007, 387, 1215–1223. [Google Scholar] [CrossRef]
  94. Tschmelak, J.; Proll, G.; Gauglitz, G. Immunosensor for estrone with an equal limit of detection as common analytical methods. Anal. Bioanal. Chem. 2004, 378, 744–745. [Google Scholar] [CrossRef] [PubMed]
  95. Hua, P.; Hole, J.P.; Wilkinson, J.S.; Proll, G.; Tschmelak, J.; Gauglitz, G.; Jackson, M.A.; Nudd, R.; Griffith, H.M.T.; Abuknesha, R.A.; et al. Integrated optical fluorescence multisensor for water pollution. Opt. Express 2005, 13, 1124. [Google Scholar] [CrossRef]
  96. Miyashita, M.; Shimada, T.; Miyagawa, H.; Akamatsu, M. Surface plasmon resonance-based immunoassay for 17β-estradiol and its application to the measurement of estrogen receptor-binding activity. Anal. Bioanal. Chem. 2005, 381, 667–673. [Google Scholar] [CrossRef]
  97. Pemberton, R.M.; Mottram, T.T.; Hart, J.P. Development of a screen-printed carbon electrochemical immunosensor for picomolar concentrations of estradiol in human serum extracts. J. Biochem. Biophys. Methods 2005, 63, 201–212. [Google Scholar] [CrossRef]
  98. Butler, D.; Guilbault, G.G. Disposable amperometric immunosensor for the detection of 17-β estradiol using screen-printed electrodes. Sensors Actuators, B Chem. 2006, 113, 692–699. [Google Scholar] [CrossRef]
  99. Liu, X.; Wong, D.K.Y. Picogram-detection of estradiol at an electrochemical immunosensor with a gold nanoparticle|Protein G-(LC-SPDP)-scaffold. Talanta 2009, 77, 1437–1443. [Google Scholar] [CrossRef] [PubMed]
  100. Martínez, N.A.; Schneider, R.J.; Messina, G.A.; Raba, J. Modified paramagnetic beads in a microfluidic system for the determination of ethinylestradiol (EE2) in river water samples. Biosens. Bioelectron. 2010, 25, 1376–1381. [Google Scholar] [CrossRef]
  101. Olowu, R.A.; Arotiba, O.; Mailu, S.N.; Waryo, T.T.; Baker, P.; Iwuoha, E. Electrochemical aptasensor for endocrine disrupting 17β-estradiol based on a Poly(3,4-ethylenedioxylthiopene)-gold nanocomposite platform. Sensors 2010, 10, 9872–9890. [Google Scholar] [CrossRef] [Green Version]
  102. Lin, Z.; Chen, L.; Zhang, G.; Liu, Q.; Qiu, B.; Cai, Z.; Chen, G. Label-free aptamer-based electrochemical impedance biosensor for 17β-estradiol. Analyst 2012, 137, 819–822. [Google Scholar] [CrossRef]
  103. Chaisuwan, N.; Xu, H.; Wu, G.; Liu, J. A highly sensitive differential pulse anodic stripping voltammetry for determination of 17Β-estradiol (E2) using CdSe quantum dots based on indirect competitive immunoassay. Biosens. Bioelectron. 2013, 46, 150–154. [Google Scholar] [CrossRef] [PubMed]
  104. Kanso, H.; Barthelmebs, L.; Inguimbert, N.; Noguer, T. Immunosensors for estradiol and ethinylestradiol based on new synthetic estrogen derivatives: Application to wastewater analysis. Anal. Chem. 2013, 85, 2397–2404. [Google Scholar] [CrossRef] [PubMed]
  105. Ke, H.; Liu, M.; Zhuang, L.; Li, Z.; Fan, L.; Zhao, G. A Fetomolar level 17β-estradiol electrochemical aptasensor constructed on hierachical dendritic gold modified boron-doped diamond electrode. Electrochim. Acta 2014, 137, 146–153. [Google Scholar] [CrossRef]
  106. Huang, K.J.; Liu, Y.J.; Shi, G.W.; Yang, X.R.; Liu, Y.M. Label-free aptamer sensor for 17β-estradiol based on vanadium disulfide nanoflowers and Au nanoparticles. Sensors Actuators, B Chem. 2014, 201, 579–585. [Google Scholar] [CrossRef]
  107. Huang, K.J.; Liu, Y.J.; Zhang, J.Z.; Liu, Y.M. A novel aptamer sensor based on layered tungsten disulfide nanosheets and Au nanoparticles amplification for 17β-estradiol detection. Anal. Methods 2014, 6, 8011–8017. [Google Scholar] [CrossRef]
  108. Zhu, B.; Alsager, O.A.; Kumar, S.; Hodgkiss, J.M.; Travas-Sejdic, J. Label-free electrochemical aptasensor for femtomolar detection of 17β-estradiol. Biosens. Bioelectron. 2015, 70, 398–403. [Google Scholar] [CrossRef] [PubMed]
  109. Fan, L.; Zhao, G.; Shi, H.; Liu, M. A simple and label-free aptasensor based on nickel hexacyanoferrate nanoparticles as signal probe for highly sensitive detection of 17β-estradiol. Biosens. Bioelectron. 2015, 68, 303–309. [Google Scholar] [CrossRef]
  110. Seifert, M.; Haindl, S.; Hock, B. Development of an enzyme linked receptor assay (ELRA) for estrogens and xenoestrogens. Anal. Chim. Acta 1999, 386, 191–199. [Google Scholar] [CrossRef]
  111. Usami, M.; Mitsunaga, K.; Ohno, Y. Estrogen receptor binding assay of chemicals with a surface plasmon resonance biosensor. J. Steroid Biochem. Mol. Biol. 2002, 81, 47–55. [Google Scholar] [CrossRef]
  112. Rich, R.L.; Hoth, L.R.; Geoghegan, K.F.; Brown, T.A.; Lemotte, P.K.; Simons, S.P.; Hensley, P.; Myszka, D.G. Kinetic analysis of estrogen receptor/ligand interactions. Proc. Natl. Acad. Sci. USA 2002, 99, 8562–8567. [Google Scholar] [CrossRef] [Green Version]
  113. Kim, B.K.; Li, J.; Im, J.E.; Ahn, K.S.; Park, T.S.; Cho, S.I.; Kim, Y.R.; Lee, W.Y. Impedometric estrogen biosensor based on estrogen receptor alpha-immobilized gold electrode. J. Electroanal. Chem. 2012, 671, 106–111. [Google Scholar] [CrossRef]
  114. Pearson, J.; Gill, A.; Margison, G.P.; Vadgama, P.; Povey, A.C. A rapid receptor-ligand assay determination of estrogens using surface plasmon resonance. In Proceedings of the Sensors and Actuators, B: Chemical; Elsevier: Amsterdam, The Netherlands, 2001; Volume 76, pp. 1–7. [Google Scholar]
  115. La Spina, R.; Ferrero, V.E.V.; Aiello, V.; Pedotti, M.; Varani, L.; Lettieri, T.; Calzolai, L.; Haasnoot, W.; Colpo, P. Label-free biosensor detection of endocrine disrupting compounds using engineered estrogen receptors. Biosensors 2017, 8, 1. [Google Scholar] [CrossRef] [Green Version]
  116. Furst, A.L.; Hoepker, A.C.; Francis, M.B. Quantifying hormone disruptors with an engineered bacterial biosensor. ACS Cent. Sci. 2017, 3, 110–116. [Google Scholar] [CrossRef] [Green Version]
  117. Gierach, I.; Shapero, K.; Eyster, T.W.; Wood, D.W. Bacterial biosensors for evaluating potential impacts of estrogenic endocrine disrupting compounds in multiple species. Environ. Toxicol. 2013, 28, 179–189. [Google Scholar] [CrossRef]
  118. Liang, R.; Zhou, J.; Liu, J. Construction of a bacterial assay for estrogen detection based on an estrogen-sensitive intein. Appl. Environ. Microbiol. 2011, 77, 2488–2495. [Google Scholar] [CrossRef] [Green Version]
  119. Zutz, C.; Wagener, K.; Yankova, D.; Eder, S.; Möstl, E.; Drillich, M.; Rychli, K.; Wagner, M.; Strauss, J. A robust high-throughput fungal biosensor assay for the detection of estrogen activity. Steroids 2017, 126, 57–65. [Google Scholar] [CrossRef] [PubMed]
  120. Wozei, E.; Hermanowicz, S.W.; Holman, H.Y.N. Developing a biosensor for estrogens in water samples: Study of the real-time response of live cells of the estrogen-sensitive yeast strain RMY/ER-ERE using fluorescence microscopy. Biosens. Bioelectron. 2006, 21, 1654–1658. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  121. Hahn, T.; Tag, K.; Riedel, K.; Uhlig, S.; Baronian, K.; Gellissen, G.; Kunze, G. A novel estrogen sensor based on recombinant Arxula adeninivorans cells. Biosens. Bioelectron. 2006, 21, 2078–2085. [Google Scholar] [CrossRef] [PubMed]
  122. Fine, T.; Leskinen, P.; Isobe, T.; Shiraishi, H.; Morita, M.; Marks, R.S.; Virta, M. Luminescent yeast cells entrapped in hydrogels for estrogenic endocrine disrupting chemical biodetection. Biosens. Bioelectron. 2006, 21, 2263–2269. [Google Scholar] [CrossRef]
  123. Awais, M.; Sato, M.; Sasaki, K.; Umezawa, Y. A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells. Anal. Chem. 2004, 76, 2181–2186. [Google Scholar] [CrossRef] [PubMed]
  124. Soto, A.M.; Sonnenschein, C.; Chung, K.L.; Fernandez, M.F.; Olea, N.; Olea Serrano, F. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. In Proceedings of the Environmental Health Perspectives; Public Health Services, US Department of Health and Human Services: Boston, MA, USA, 1995; Volume 103, pp. 113–122. [Google Scholar]
  125. Legler, J.; Van Den Brink, C.E.; Brouwer, A.; Murk, A.J.; Van Der Saag, P.T.; Vethaak, A.D.; Van Der Burg, B. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol. Sci. 1999, 48, 55–66. [Google Scholar] [CrossRef]
  126. Zuo, J.; Niu, Q.W.; Chua, N.H. An estrogen receptor-based transactivator XVE mediates highly inducible gene expression in transgenic plants. Plant J. 2000, 24, 265–273. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  127. Thomas-Jones, E.; Thorpe, K.; Harrison, N.; Thomas, G.; Morris, C.; Hutchinson, T.; Woodhead, S.; Tyler, C. Dynamics of estrogen biomarker responses in rainbow trout exposed to 17β-estradiol and 17α-ethinylestradiol. Environ. Toxicol. Chem. 2003, 22, 3001–3008. [Google Scholar] [CrossRef]
  128. Lee, O.; Green, J.M.; Tyler, C.R. Transgenic fish systems and their application in ecotoxicology. Crit. Rev. Toxicol. 2015, 45, 124–141. [Google Scholar] [CrossRef]
  129. Kurauchi, K.; Nakaguchi, Y.; Tsutsumi, M.; Hori, H.; Kurihara, R.; Hashimoto, S.; Ohnuma, R.; Yamamoto, Y.; Matsuoka, S.; Kawai, S.; et al. In vivo visual reporter system for detection of estrogen-like substances by transgenic medaka. Environ. Sci. Technol. 2005, 39, 2762–2768. [Google Scholar] [CrossRef] [PubMed]
  130. Zeng, Z.; Shan, T.; Tong, Y.; Lam, S.H.; Gong, Z. Development of estrogen-responsive transgenic medaka for environmental monitoring of endocrine disrupters. Environ. Sci. Technol. 2005, 39, 9001–9008. [Google Scholar] [CrossRef]
  131. Salam, M.A.; Sawada, T.; Ohya, T.; Ninomiya, K.; Hayashi, S. Detection of environmental estrogenicity using transgenic medaka hatchlings (Oryzias latipes) expressing the GFP-tagged choriogenin L Gene. J. Environ. Sci. Heal. Part A Toxic/Hazardous Subst. Environ. Eng. 2008, 43, 272–277. [Google Scholar] [CrossRef]
  132. Cho, Y.S.; Kim, D.S.; Nam, Y.K. Characterization of estrogen-responsive transgenic marine medaka Oryzias dancena germlines harboring red fluorescent protein gene under the control by endogenous choriogenin H promoter. Transgenic Res. 2013, 22, 501–517. [Google Scholar] [CrossRef] [PubMed]
  133. Legler, J.; Broekhof, J.L.M.; Brouwer, A.; Lanser, P.H.; Murk, A.J.; Van Der Saag, P.T.; Dick Vethaak, A.; Wester, P.; Zivkovic, D.; Van Der Burg, B. A novel in vivo bioassay for (xeno-)estrogens using transgenic zebrafish. Environ. Sci. Technol. 2000, 34, 4439–4444. [Google Scholar] [CrossRef] [Green Version]
  134. Chen, H.; Hu, J.; Yang, J.; Wang, Y.; Xu, H.; Jiang, Q.; Gong, Y.; Gu, Y.; Song, H. Generation of a fluorescent transgenic zebrafish for detection of environmental estrogens. Aquat. Toxicol. 2010, 96, 53–61. [Google Scholar] [CrossRef]
  135. Brion, F.; Le Page, Y.; Piccini, B.; Cardoso, O.; Tong, S.K.; Chung, B.C.; Kah, O. Screening estrogenic activities of chemicals or mixtures in vivo using transgenic (cyp19a1b-GFP) zebrafish embryos. PLoS ONE 2012, 7, e36069. [Google Scholar] [CrossRef] [Green Version]
  136. Gorelick, D.A.; Iwanowicz, L.R.; Hung, A.L.; Blazer, V.S.; Halpern, M.E. Transgenic zebrafish reveal tissue-specific differences in estrogen signaling in response to environmental water samples. Environ. Health Perspect. 2014, 122, 356–362. [Google Scholar] [CrossRef] [Green Version]
  137. Xiong, G.; Luo, Y.; Jin, S.; Maser, E. Cis- and trans-regulatory elements of 3α-hydroxysteroid dehydrogenase/carbonyl reductase as biosensor system for steroid determination in the environment. Chem. Biol. Interact. 2009, 178, 215–220. [Google Scholar] [CrossRef] [PubMed]
  138. Maser, E.; Xiong, G. The Comamonas testosteroni steroid biosensor system (COSS)-Reflection on other methods. J. Steroid Biochem. Mol. Biol. 2010, 121, 633–640. [Google Scholar] [CrossRef] [PubMed]
  139. Grazon, C.; Baer, R.C.; Kuzmanović, U.; Nguyen, T.; Chen, M.; Zamani, M.; Chern, M.; Aquino, P.; Zhang, X.; Lecommandoux, S.; et al. A progesterone biosensor derived from microbial screening. Nat. Commun. 2020, 11, 1–10. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Proposed estrogen degradation pathway in C. tardaugens NBRC 16725. Compound names are indicated with an abbreviation: (E2) estradiol; (E1) estrone; (4-OHE1) 4-hydroxystrone; (HIP) 3aα-H -4α(3′-propanoate)-7aβ-methylhexahydro-1,5-indanedione. Enzyme names are: (17β-hsd) 3β, 17β-hydroxysteroid dehydrogenase; (edcA) E1 4-hydroxylase; (edcB) 4-OHE1 4,5-dioxygenase; (edcC) meta-cleavage product decarboxylase. The catalytic genes of C. tardaugens are indicated in italics, with the nomenclature EGO55_xxxxx.
Figure 1. Proposed estrogen degradation pathway in C. tardaugens NBRC 16725. Compound names are indicated with an abbreviation: (E2) estradiol; (E1) estrone; (4-OHE1) 4-hydroxystrone; (HIP) 3aα-H -4α(3′-propanoate)-7aβ-methylhexahydro-1,5-indanedione. Enzyme names are: (17β-hsd) 3β, 17β-hydroxysteroid dehydrogenase; (edcA) E1 4-hydroxylase; (edcB) 4-OHE1 4,5-dioxygenase; (edcC) meta-cleavage product decarboxylase. The catalytic genes of C. tardaugens are indicated in italics, with the nomenclature EGO55_xxxxx.
Genes 12 01846 g001
Figure 2. Scheme of the C. tardaugens NBRC 16725 estrogen degradation cluster (edc). Operons OpA, OpB and the intergenic region are depicted with a line: red, purple and yellow, respectively. Genes annotated as tetR (EGO55_13520), cytochrome P450 hydroxylase (EGO55_13525), hydratase (EGO55_13530), lipid-transfer protein (EGO55_13535), enoyl-CoA hydratase/ isomerase (EGO55_13540), 2-ketoacyclohexanecarboxyl-CoA (EGO55_13545), acetyl-CoA acyltransferase (EGO55_13550), hydroxymethylglutaryl-CoA synthase (EGO55_13555), 3-hydroxyacyl-CoA dehydrogenase (EGO55_13560), acyl-CoA dehydrogenase (EGO55_13565), 4-hydroxyestrone-4,5-dioxygenase (EGO55_13570), vicinal oxygen chelate containing protein (EGO55_13575), indolepyruvate ferredoxin oxidoreductase (EGO55_13580), acyl-CoA dehydrogenase (EGO55_13585), MaoC dehydratase (EGO55_13590), MaoC dehydratase (EGO55_13595) and TonB dependent receptor (EGO55_13600) are also shown.
Figure 2. Scheme of the C. tardaugens NBRC 16725 estrogen degradation cluster (edc). Operons OpA, OpB and the intergenic region are depicted with a line: red, purple and yellow, respectively. Genes annotated as tetR (EGO55_13520), cytochrome P450 hydroxylase (EGO55_13525), hydratase (EGO55_13530), lipid-transfer protein (EGO55_13535), enoyl-CoA hydratase/ isomerase (EGO55_13540), 2-ketoacyclohexanecarboxyl-CoA (EGO55_13545), acetyl-CoA acyltransferase (EGO55_13550), hydroxymethylglutaryl-CoA synthase (EGO55_13555), 3-hydroxyacyl-CoA dehydrogenase (EGO55_13560), acyl-CoA dehydrogenase (EGO55_13565), 4-hydroxyestrone-4,5-dioxygenase (EGO55_13570), vicinal oxygen chelate containing protein (EGO55_13575), indolepyruvate ferredoxin oxidoreductase (EGO55_13580), acyl-CoA dehydrogenase (EGO55_13585), MaoC dehydratase (EGO55_13590), MaoC dehydratase (EGO55_13595) and TonB dependent receptor (EGO55_13600) are also shown.
Genes 12 01846 g002
Figure 3. Scheme of gene expression of estrogen degradation cluster (edc) in C. tardaugens NBRC 16725 cells when grown on E2 compared to PYR condition. (a) Mapping of RNA-Seq raw reads against edc cluster sequence obtained in PYR and E2 conditions. (b) Scheme of edc cluster. (c) Induction levels of the edc cluster measured as fold change (FC).
Figure 3. Scheme of gene expression of estrogen degradation cluster (edc) in C. tardaugens NBRC 16725 cells when grown on E2 compared to PYR condition. (a) Mapping of RNA-Seq raw reads against edc cluster sequence obtained in PYR and E2 conditions. (b) Scheme of edc cluster. (c) Induction levels of the edc cluster measured as fold change (FC).
Genes 12 01846 g003
Figure 4. Analysis of promoter sequences of the edc cluster. Sequences of the Pa, Pb, Pt and Pr regions of C. tardaugens NBRC 16725 and Pa and Pb of A. estronivorus MHB5. The -35 and -10 putative boxes are shown in red and purple, respectively. The start codons of the downstream gene are highlighted in pink and those of the gene upstream of the promoter in green, and the palindromic sequences identified are highlighted in gray. Identified palindromes are marked with yellow arrows and nucleotides that differ from the palindrome are marked with yellow stars.
Figure 4. Analysis of promoter sequences of the edc cluster. Sequences of the Pa, Pb, Pt and Pr regions of C. tardaugens NBRC 16725 and Pa and Pb of A. estronivorus MHB5. The -35 and -10 putative boxes are shown in red and purple, respectively. The start codons of the downstream gene are highlighted in pink and those of the gene upstream of the promoter in green, and the palindromic sequences identified are highlighted in gray. Identified palindromes are marked with yellow arrows and nucleotides that differ from the palindrome are marked with yellow stars.
Genes 12 01846 g004
Figure 5. Sequence alignment of the regulators encoded by EGO55_13520, MB02_RS00150 and KC8_05330, in C. tardaugens NBRC 16725 (CT), A. estronivorus MHB5 (AE) and Sphingomonas sp. KC8 (KC8), respectively. DNA-binding domains (a,c) and effector-binding domains (b,d). Identical and conserved amino acids are marked with "*" and “:”, respectively.
Figure 5. Sequence alignment of the regulators encoded by EGO55_13520, MB02_RS00150 and KC8_05330, in C. tardaugens NBRC 16725 (CT), A. estronivorus MHB5 (AE) and Sphingomonas sp. KC8 (KC8), respectively. DNA-binding domains (a,c) and effector-binding domains (b,d). Identical and conserved amino acids are marked with "*" and “:”, respectively.
Genes 12 01846 g005
Figure 6. Growth curves (OD600) of C. tardaugens strains growing in minimal medium supplemented with 2 mM E2. (a) C. tardaugens wt strain and C. tardaugens ΔedcR mutant. (b) C. tardaugens ΔedcR (pSEVA23PlexA) (ΔedcR-v) and C. tardaugens ΔedcR (pSEVA23edcR) (ΔedcR-c). The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Figure 6. Growth curves (OD600) of C. tardaugens strains growing in minimal medium supplemented with 2 mM E2. (a) C. tardaugens wt strain and C. tardaugens ΔedcR mutant. (b) C. tardaugens ΔedcR (pSEVA23PlexA) (ΔedcR-v) and C. tardaugens ΔedcR (pSEVA23edcR) (ΔedcR-c). The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Genes 12 01846 g006
Figure 7. Analysis by RT-PCR of the expression of some genes of the edc cluster in C. tardaugens wild-type and ∆edcR mutant growing in E2 and testosterone. C- is the control without RNA, gDNA is the control with genomic DNA and M is the 100 bp molecular weight marker.
Figure 7. Analysis by RT-PCR of the expression of some genes of the edc cluster in C. tardaugens wild-type and ∆edcR mutant growing in E2 and testosterone. C- is the control without RNA, gDNA is the control with genomic DNA and M is the 100 bp molecular weight marker.
Genes 12 01846 g007
Figure 8. Fluorescence intensity of the transcriptional fusions of the Pa and Pb promoter regions measured in cultures of C. tardaugens (a) and C. tardaugens ∆edcR mutant (b) transformed with the plasmids pSEVA237Pa or pSEVA237Pb, grown in NB carbon and energy source, in the presence of CDX (control) (light colors) or E1 (inducer) (dark colors). The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Figure 8. Fluorescence intensity of the transcriptional fusions of the Pa and Pb promoter regions measured in cultures of C. tardaugens (a) and C. tardaugens ∆edcR mutant (b) transformed with the plasmids pSEVA237Pa or pSEVA237Pb, grown in NB carbon and energy source, in the presence of CDX (control) (light colors) or E1 (inducer) (dark colors). The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Genes 12 01846 g008
Figure 9. Analysis by RT-PCR of the expression of the genes of the edc cluster in C. tardaugens ∆edcA mutant growing in testosterone (TES) and testosterone in the presence of E2 (E2). C- is the control without RNA, gDNA is the control with genomic DNA and M is the 100 bp molecular weight marker.
Figure 9. Analysis by RT-PCR of the expression of the genes of the edc cluster in C. tardaugens ∆edcA mutant growing in testosterone (TES) and testosterone in the presence of E2 (E2). C- is the control without RNA, gDNA is the control with genomic DNA and M is the 100 bp molecular weight marker.
Genes 12 01846 g009
Figure 10. Fluorescence intensity of cultures of E. coli DH10B (pSEVA237Pb) (pSEVA651) and E. coli DH10B (pSEVA237Pb) (pSEVA65edcR). Cultures were grown in LB in the presence of the solvent as control (solv) and the inducers, 5 µM E1 or 5 µM E2. The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Figure 10. Fluorescence intensity of cultures of E. coli DH10B (pSEVA237Pb) (pSEVA651) and E. coli DH10B (pSEVA237Pb) (pSEVA65edcR). Cultures were grown in LB in the presence of the solvent as control (solv) and the inducers, 5 µM E1 or 5 µM E2. The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Genes 12 01846 g010
Figure 11. Fluorescence intensity of cultures of E. coli DH10B (pSEVA237Pb) (pSEVA65edcR) growing in LB in the presence of the solvent as control (solv), 10 µM E1, 10 µM E2, 10 µM E3, 10 µM 4OH-E1, 10 µM EE2 and 10 µM testosterone. The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Figure 11. Fluorescence intensity of cultures of E. coli DH10B (pSEVA237Pb) (pSEVA65edcR) growing in LB in the presence of the solvent as control (solv), 10 µM E1, 10 µM E2, 10 µM E3, 10 µM 4OH-E1, 10 µM EE2 and 10 µM testosterone. The values correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Genes 12 01846 g011
Figure 12. Biosensor systems built using the strains E. coli DH10B (pSEVA237MPb) (pSEVA651) and E. coli DH10B (pSEVA237MPb) (pSEVA65edcR). Schematic representation of the pSEVA237MPb (a) and pSEVA65edcR (b) plasmids constructed to develop an estrogen biosensor system. The main elements of the plasmids have been drawn: Pb, Pb promoter region; PlexA, PlexA promoter sequence; BCD2, bicistronic RBS; msf-gfp, gene encoding the monomeric superfolder green fluorescent protein; edcR gene; T0 and T1, transcription terminators; KmR, kanamycin resistance gene; GmR, gentamycin resistance gene; OriT, transfer origin, OriV (pBBR1) and oriV (RSF1010), replication origins. The restriction enzymes used for cloning purposes are indicated. (c) Visual comparison of the liquid cultures grown in LB in the presence of the solvent as control (-) and 5 µM E1 and the 1.5 ml pellets of the cultures. (d,e) Fluorescence intensity of the recombinant strains carrying the transcriptional fusion with the Pb promoter. E. coli DH10B (pSEVA237MPb) (pSEVA651) control strain is shown in blue and E. coli DH10B (pSEVA237MPb) (pSEVA65edcR) (named as EdcR) in orange. The cultures were grown in the presence of the solvent as control (0),1, 2.5, 5, 10, 15 and 20 μM of E1 and 1, 2.5, 5, 10, 15, 20 and 30 μM of E2. The values represented correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Figure 12. Biosensor systems built using the strains E. coli DH10B (pSEVA237MPb) (pSEVA651) and E. coli DH10B (pSEVA237MPb) (pSEVA65edcR). Schematic representation of the pSEVA237MPb (a) and pSEVA65edcR (b) plasmids constructed to develop an estrogen biosensor system. The main elements of the plasmids have been drawn: Pb, Pb promoter region; PlexA, PlexA promoter sequence; BCD2, bicistronic RBS; msf-gfp, gene encoding the monomeric superfolder green fluorescent protein; edcR gene; T0 and T1, transcription terminators; KmR, kanamycin resistance gene; GmR, gentamycin resistance gene; OriT, transfer origin, OriV (pBBR1) and oriV (RSF1010), replication origins. The restriction enzymes used for cloning purposes are indicated. (c) Visual comparison of the liquid cultures grown in LB in the presence of the solvent as control (-) and 5 µM E1 and the 1.5 ml pellets of the cultures. (d,e) Fluorescence intensity of the recombinant strains carrying the transcriptional fusion with the Pb promoter. E. coli DH10B (pSEVA237MPb) (pSEVA651) control strain is shown in blue and E. coli DH10B (pSEVA237MPb) (pSEVA65edcR) (named as EdcR) in orange. The cultures were grown in the presence of the solvent as control (0),1, 2.5, 5, 10, 15 and 20 μM of E1 and 1, 2.5, 5, 10, 15, 20 and 30 μM of E2. The values represented correspond to the mean of three independent biological replicas (n = 3) and error bars correspond to SD.
Genes 12 01846 g012
Table 1. Bacterial strains and plasmids used in this study.
Table 1. Bacterial strains and plasmids used in this study.
StrainsGenotype and CharacteristicsSource/Reference
C. tardaugens
NBRC 16725wild type strain (ARI-1)[20]
RfRRfR strain efficient for conjugation[22]
ΔedcAC. tardaugens NBRC 16725 ΔEGO55_13525[23]
ΔedcRC. tardaugens NBRC 16725 ΔEGO55_13520This study
E. coli
DH10BF, mcrA, Δ(mrr hsdRMS-mcrBC), Φ80dlacZΔM15, ΔlacX74, deoR, recA1, araD139, Δ(ara-leu)7697, galU, galK, λ, rpsL, endA1, nupGInvitrogen
HB101supE44, ara14, galK2, leuB, lacY1, ∆(gpt-proA)62, rpsL20, xyl-5, mtl-1, recA13, ∆(mcrC-mrr), hsdS20 (rBmB), SmR[27]
Plasmids
pK18mobsacBKmR, ColE oriV, Mob+, lacZα, sacB; vector for allelic exchange homologous recombination mutagenesis[28]
pK18edcRpK18mobsacB derivative used for EGO55_13520 deletionThis study
pSEVA237PlexAKmR, oriV (pBBR1), constituve expression of gfp gene under the control of the PlexA promoter[29]
pSEVA23PlexApSEVA237PlexA where gfp was deleted using XbaI-SpeI restriction enzymes and served as empty vector[23]
pSEVA23edcRpSEVA237PlexA where gfp gene was replaced by EGO55_13520This study
pSEVA237PapSEVA237PlexA where PlexA promoter was replaced by PaThis study
pSEVA237PbpSEVA237PlexA where PlexA promoter was replaced by PbThis study
pSEVA237PtpSEVA237PlexA where PlexA promoter was replaced by PtThis study
pSEVA237M-BCD2-14g KmR, pSEVA237M derivative, synthetic bicistronic RBS BCD2, P14g promoterKindly provided by P. Nikel
pSEVA237MPbKmR, pSEVA237M-BCD2-14g derivative where P14g promoter was replaced by Pb This study
pSEVA651GmR, oriV (RSF1010), standard MCS[30]
pSEVA65edcR pSEVA651 containing EGO55_13520 gene expressed constitutively under PlexA promoterThis study
KmR, kanamycin resistance gene.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ibero, J.; Galán, B.; García, J.L. Identification of the EdcR Estrogen-Dependent Repressor in Caenibius tardaugens NBRC 16725: Construction of a Cellular Estradiol Biosensor. Genes 2021, 12, 1846. https://doi.org/10.3390/genes12121846

AMA Style

Ibero J, Galán B, García JL. Identification of the EdcR Estrogen-Dependent Repressor in Caenibius tardaugens NBRC 16725: Construction of a Cellular Estradiol Biosensor. Genes. 2021; 12(12):1846. https://doi.org/10.3390/genes12121846

Chicago/Turabian Style

Ibero, Juan, Beatriz Galán, and José L. García. 2021. "Identification of the EdcR Estrogen-Dependent Repressor in Caenibius tardaugens NBRC 16725: Construction of a Cellular Estradiol Biosensor" Genes 12, no. 12: 1846. https://doi.org/10.3390/genes12121846

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop